Diseases, Conditions, Syndromes

Sanofi, GSK to start clinical tests of virus vaccine

French pharmaceutical giant Sanofi on Thursday said it would start human trials of the potential coronavirus vaccine it is developing with British peer GSK, following promising preliminary tests.

Vaccination

EU joins WHO's coronavirus vaccine access plan

The European Commission said Monday it would participate in the World Health Organization mechanism to facilitate poor countries' access to coronavirus vaccines, offering 400 million euros ($477 million) in guarantees.

Diseases, Conditions, Syndromes

EU reaches virus vaccine deal with CureVac

The EU said Thursday it has concluded talks with German pharmaceutical firm CureVac, aiming to secure 225 million doses of a potential coronavirus vaccine.

Diseases, Conditions, Syndromes

Virus-linked border moves raise fears on free travel in EU

As European countries struggle to manage spikes in coronavirus cases, concern is mounting about a "second wave" of uncoordinated border restrictions within Europe that threatens the free movement of goods and peopleā€”a foundation ...

Diseases, Conditions, Syndromes

US to put up $2.1 bn for Sanofi, GSK coronavirus vaccine

Pharma giants Sanofi and GSK will receive up to $2.1 billion from the US government for the development of a COVID-19 vaccine, the companies said Friday, as the world continues to be ravaged by the coronavirus epidemic.

Diseases, Conditions, Syndromes

EU orders 30,000 remdesivir coronavirus treatments

The European Commission has ordered 30,000 treatment doses of the antiviral medication remdesivir from US drugs giant Gilead, it announced Wednesday.

page 17 from 32